Sai Ramana Ponugoti appointed as CEO, ICH of Piramal Pharma
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Immedica to commence a cash tender offer to acquire all issued and outstanding shares of Marinus for an enterprise value of approximately US$ 151 million
Subscribe To Our Newsletter & Stay Updated